Top Markets
Coin of the day
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Rang în acțiuni #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Preț acțiune
$8.46
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$514.33M
Schimbare (1 zi)
-2.08%
Schimbare (1 an)
128.03%
Țară
US
Tranzacționează Kyverna Therapeutics, Inc. (KYTX)

Categorie

Istoric al prețului acțiunii pentru Kyverna Therapeutics, Inc. (KYTX)
Cel mai mare preț de închidere: $8.33 pe 2026-08-01

Cel mai mic preț de închidere: $28.70 pe 2024-02-01
Istoric al prețului acțiunii pentru Kyverna Therapeutics, Inc. din 2024 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -5.16%
2025 89.56%
2024 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$752.76 6.28%
CH